Abpro Holdings, Inc. (ABPO)
0.2293
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Abpro Holdings EPS Diluted (Quarterly) : -0.1594 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1594 |
| March 31, 2026 | -0.2289 |
| December 31, 2025 | 2.062 |
| September 30, 2025 | -0.6339 |
| June 30, 2025 | -1.556 |
| March 31, 2025 | -2.290 |
| December 31, 2024 | -7.974 |
| September 30, 2024 | -0.0411 |
| June 30, 2024 | -3.812 |
| March 31, 2024 | 0.21 |
| Date | Value |
|---|---|
| December 31, 2023 | -5.976 |
| September 30, 2023 | -0.0041 |
| June 30, 2023 | 0.0496 |
| March 31, 2023 | 0.0552 |
| December 31, 2022 | 0.0389 |
| September 30, 2022 | 0.0174 |
| June 30, 2022 | -0.0052 |
| March 31, 2022 | -0.0331 |
| December 31, 2021 | 0.00 |
| October 31, 2021 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.94M |
| Total Expenses (Quarterly) | 0.94M |
| Enterprise Value | -2.164M |
| Earnings Yield | 453.5% |
| Normalized Earnings Yield | -401.74 |